In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 148 for your search:
Drug:  idarubicin hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: AML99<=65 años, NCT00390715

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 75 and under
Sponsor: Other
Protocol IDs: Pethema LPA-99 protocol, NCT00465933

3.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Any age
Sponsor: Other
Protocol IDs: PETHEMA-LAM07, NCT01041040

4.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor: Other
Protocol IDs: AML-01.10, NCT01587430

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDL-3-251, MSKCC-93131, NCI-V94-0469

6.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21 at relapse
Sponsor: NCI
Protocol IDs: POG-9410, POG-SIMAL-8

7.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1586

8.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: AMLSG07-04, NCT00151242

9.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: MYFLAI07, NCT00909168

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 17
Sponsor:
Protocol IDs: GER-GPOH-AML-BFM-93, EU-93008

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor: Other
Protocol IDs: CDR0000063311, EORTC-06931, NCT00002549

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI, Other
Protocol IDs: CDR0000063574, MDA-DM-94017, NCI-T94-0040D, DM94-017, T94-0040, NCT00002565

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: at least 1 + under 20 at diag.
Sponsor: NCI
Protocol IDs: CCG-1941

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to physiologic 59
Sponsor: Other
Protocol IDs: MRC-LEUK-AML12, EU-95001, NCT00002658

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 74
Sponsor:
Protocol IDs: EORTC-06952, ITA-GIMEMA-AIEOP-1, NCT00002701

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 61 to 80
Sponsor: Other
Protocol IDs: EORTC-06954, ITA-GIMEMA-AML13, NCT00002719

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MRC-LEUK-AML-R, EU-95037

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: GER-CML-3, EU-95042, NCT00002771

19.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 22
Sponsor: NCI
Protocol IDs: NCI-2012-01834, 2961, U10CA098543, CDR0000064883, COG-2961, CCG-2961, NCT00002798

20.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: 1961, CCG-1961, CDR0000064953, NCT00002812

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI, Other
Protocol IDs: 1951, CCG-1951, CDR0000064968, NCT00002816

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 59
Sponsor: NCI, Other
Protocol IDs: MDA DM95-121, P30CA016672, NCI-V96-1010, CDR0000065044, NCT00002835

23.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000065146, MRC-LEUK-CML-2000, ECOG-E7995, MRC-LEUK-CML-IV, MRC-LEUK-CML-IVa, EU-96029, E7995, NCT00002868

24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16-60
Sponsor: Other
Protocol IDs: CDR0000065336, EORTC-06961, NCT00002926

25.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Over 25
Sponsor: Other
Protocol IDs: CDR0000065406, RPCI-DS-96-48, NCI-G97-1152, NCT00002945
1     
New Search